RGS5 and gastric cancer: RGS3 does not appear to be associated with prognosis in patients with gastric cancer, whereas RGS5, which has been shown to be associated with abnormal vascular formation, is a prognostic risk factor in three gastric cancer cohorts (Wang et al., 2010).